Prelude Therapeutics
Clinical trials sponsored by Prelude Therapeutics, explained in plain language.
-
Early-Stop cancer trial tests novel drug duo for tough tumors
Disease control TerminatedThis study tested the safety and effectiveness of a new drug, PRT3789, combined with an existing immunotherapy (pembrolizumab) for people with advanced solid tumors that have a specific genetic change called a SMARCA4 mutation. The trial was designed for patients whose cancer had…
Phase: PHASE2 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 04:12 UTC
-
New pill targets genetic weakness in advanced cancers
Disease control TerminatedThis early-stage study tested a new oral drug called PRT7732 in people with advanced or metastatic solid tumors that have a specific genetic change (SMARCA4 mutation). The main goals were to find a safe dose, see how the body processes the drug, and look for early signs that it m…
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC